RGA Investment Advisors discusses AI integration and new stakes in Celsius Holdings and Lattice Semiconductor. Read the full ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarter2025 year-end cash and cash equivalents of $226.

Each year, families leave money on the table by moving too quickly to file their taxes. Experts explained the tax breaks middle-class families may be missing.